COR Cencora, Inc.
Healthcare$274.91+3.57%ClosedMarket Cap: $53.49B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$389.29
Target (Median)
$412.00
Target Range
$331.00 - $440.00
Upside from current price: 41.6%
Rating Distribution
4 Strong Buy8 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-07 | UBS | maintain | Buy | Buy |
| 2026-05-07 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-07 | Baird | maintain | Outperform | Outperform |
| 2026-05-07 | Citigroup | maintain | Buy | Buy |
| 2026-02-13 | Barclays | maintain | Overweight | Overweight |
| 2026-02-10 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-10 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-05 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-01-29 | Morgan Stanley | upgrade | Overweight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $19.80 | $357.82B | 8 |
| Sat Sep 30 | $21.97 | $380.58B | 3 |
| Sun Sep 30 | $25.12 | $410.08B | 1 |
| Mon Sep 30 | $30.74 | $405.50B | 1 |